SAKAR

Sakar Healthcare Share Price

₹291.03 -8.37 (-2.8%)

25 Apr, 2025 21:11

SIP TrendupStart SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹284
  • High
  • ₹300
  • 52 Week Low
  • ₹210
  • 52 Week High
  • ₹375
  • Open Price₹291
  • Previous Close₹299
  • Volume30,853

Investment Returns

  • Over 1 Month + 22.17%
  • Over 3 Month -3.47%
  • Over 6 Month -6.53%
  • Over 1 Year -21.04%
SIP Lightning

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 43
  • PEG Ratio
  • 2.2
  • Market Cap Cr
  • 639
  • P/B Ratio
  • 2.4
  • Average True Range
  • 19.21
  • EPS
  • 6.79
  • Dividend Yield
  • 0
  • MACD Signal
  • 9.3
  • RSI
  • 62.42
  • MFI
  • 85.34

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹291.03
-8.37 (-2.8%)
pointer
  • stock-down_img
  • Bearish Moving Average 3
  • stock-up_img
  • Bullish Moving Average 13
  • 20 Day
  • ₹270.71
  • 50 Day
  • ₹262.91
  • 100 Day
  • ₹272.27
  • 200 Day
  • ₹290.17

Resistance and Support

291.68 Pivot Speed
  • R3 315.35
  • R2 307.68
  • R1 299.35
  • S1 283.35
  • S2 275.68
  • S3 267.35

What's your outlook on Sakar Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 170.40 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 10% is healthy, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 22% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 42 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-08 Quarterly Results
2024-10-22 Quarterly Results
2024-08-13 Quarterly Results
2024-05-21 Audited results
2024-02-10 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

53.58%
13.6%
15.93%
16.89%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹291 As on 25 April, 2025 | 20:57

The Market Cap of Sakar Healthcare is ₹638.8 Cr As on 25 April, 2025 | 20:57

The P/E ratio of Sakar Healthcare is 43 As on 25 April, 2025 | 20:57

The PB ratio of Sakar Healthcare is 2.4 As on 25 April, 2025 | 20:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23